← Reviews
Open accessAnalysisOct 9, 2026

Resistance training with aerobic active recovery in obesity and metabolic syndrome: narrative review and protocol proposal

No randomized chronic intervention trial directly evaluating resistance training with aerobic active recovery exists for adults with obesity or metabolic syndrome.

Evidence levelDNarrative / animal / in vitro / mechanistic
Study typeother
Sample—
Effect directionInsufficient
CertaintyVery low
Clinical applicabilityVery low
Overinterpretation risk1/5 · Low
PICO
Population—
Intervention—
Comparator—
Outcome—

Context

Replacing passive inter-set rest with low-impact aerobic activity is a proposed session architecture for obesity and metabolic syndrome populations. Whether this strategy yields superior cardiometabolic benefits over conventional training remains unanswered.

What the study showed

The review found no randomized trials directly testing the proposed intervention in the target population. The presented rationale derives entirely from indirect evidence drawn from aerobic, resistance, and combined training studies in adjacent cohorts. Microbiota and DNA-methylation findings are heterogeneous and not RT-AR-specific.

How it was done

Narrative review with structured searches in PubMed/MEDLINE and Scopus, synthesizing systematic reviews, meta-analyses, controlled intervention studies, and mechanistic studies. Dedicated high-sensitivity searches specifically targeting inter-set aerobic active recovery were conducted.

Risk of bias

The complete absence of direct trials makes the entire rationale hypothetical and reliant on extrapolation; the authors themselves acknowledge partial applicability of adjacent-cohort data. This analysis is based solely on the published abstract.

Interpretation limit

What this study does NOT prove

This study does not prove that aerobic active recovery between sets produces superior cardiometabolic outcomes compared to passive rest in any population.

In clinical practice

RT-AR has no direct empirical support for clinical recommendation in obesity or metabolic syndrome. Clinicians should not adopt the proposal as a validated protocol prior to randomized trials.

Limitations

The complete absence of direct trials makes the entire rationale hypothetical and reliant on extrapolation; the authors themselves acknowledge partial applicability of adjacent-cohort data. This analysis is based solely on the published abstract.

Technical appendix

Version history

  • 1.0 · 2026-10-09 — Auto-generated under Evidence Standard v1.0
Source: DOI 10.3390/jcm15176671 · 2026

Microbiota Weekly

The week in microbiota evidence, in your language. Structured summaries, traceable to the source.